STUDIES.

SCIENTIFIC RESEARCH
IN FOCUS.

NOA-18/Improve-Codel (improvement of functional results in newly diagnosed glioma grade 2/3 with co-deletion of 1p/19q)

NOA-18/Improve-Codel (improvement of functional results in newly diagnosed glioma grade 2/3 with co-deletion of 1p/19q)

The aim of the NOA-18-Trial is to demonstrate superiority of initial temozolomide/CCNU chemotherapy followed by partial brain irradiation plus PCV in progression compared to radiochemotherapy with PCV in overall survival without permanent functional deterioration.